BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2301698)

  • 1. Immunohistochemical staining with monoclonal Ab B72.3 in benign and malignant breast disease.
    Tavassoli FA; Jones MW; Majeste RM; Bratthauer GL; O'Leary TJ
    Am J Surg Pathol; 1990 Feb; 14(2):128-33. PubMed ID: 2301698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
    Kővári B; Báthori Á; Cserni G
    Pathobiology; 2015; 82(6):259-63. PubMed ID: 26562027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary cancer antigen recognized by monoclonal antibody B72.3 in apocrine metaplasia of the human breast.
    Castagna M; Nuti M; Squartini F
    Cancer Res; 1987 Feb; 47(3):902-6. PubMed ID: 3542197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histologic spectrum of apocrine breast proliferations: a comparative study of morphology and DNA content by image analysis.
    Raju U; Zarbo RJ; Kubus J; Schultz DS
    Hum Pathol; 1993 Feb; 24(2):173-81. PubMed ID: 8381766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions.
    Bier B; Douglas-Jones A; Tötsch M; Dockhorn-Dworniczak B; Böcker W; Jasani B; Schmid KW
    Breast Cancer Res Treat; 1994; 30(3):213-21. PubMed ID: 7981441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.
    Celis JE; Moreira JM; Gromova I; Cabezón T; Gromov P; Shen T; Timmermans V; Rank F
    Mol Oncol; 2007 Jun; 1(1):97-119. PubMed ID: 19383289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study.
    Gottlieb C; Raju U; Greenwald KA
    Mod Pathol; 1990 Mar; 3(2):135-40. PubMed ID: 1691493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.
    Honma N; Takubo K; Arai T; Younes M; Kasumi F; Akiyama F; Sakamoto G
    APMIS; 2006 Oct; 114(10):712-9. PubMed ID: 17004974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
    Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of monoclonal antibody B72.3 for the diagnosis of breast carcinoma: experience with the first commercially available source.
    Prey MU; Bedrossian CW; Masood S
    Hum Pathol; 1991 Jun; 22(6):598-602. PubMed ID: 1864590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple mucin-type carbohydrate antigens (T, sialosyl-T, Tn and sialosyl-Tn) in breast carcinogenesis.
    Schmitt FC; Figueiredo P; Lacerda M
    Virchows Arch; 1995; 427(3):251-8. PubMed ID: 7496593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma.
    Goldstein NS; O'Malley BA
    Am J Clin Pathol; 1997 May; 107(5):561-6. PubMed ID: 9128269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Histologic Spectrum of Apocrine Lesions of the Breast.
    Durham JR; Fechner RE
    Am J Clin Pathol; 2000 May; 113(suppl_1):S3-18. PubMed ID: 11993707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody B72.3 in benign breast lesions.
    Soomro S; Shousha S
    J Clin Pathol; 1990 Dec; 43(12):1026-8. PubMed ID: 2266175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study.
    Giri DD; Dundas SA; Nottingham JF; Underwood JC
    Histopathology; 1989 Dec; 15(6):575-84. PubMed ID: 2606454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up.
    Seidman JD; Ashton M; Lefkowitz M
    Cancer; 1996 Jun; 77(12):2529-37. PubMed ID: 8640702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extratumoral breast tissue in breast cancer patients: a multinational study of variations with age and country of residence in low- and high-risk countries. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Aaman TB; Stalsberg H; Thomas DB
    Int J Cancer; 1997 May; 71(3):333-9. PubMed ID: 9139863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
    Elayat G; Selim AG; Wells CA
    Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoperoxidase studies by monoclonal antibody B72.3 applied to breast aspirates: diagnostic considerations.
    Lundy J; Kline TS; Lozowski M; Chao S
    Diagn Cytopathol; 1988; 4(2):95-8. PubMed ID: 3072171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical Apocrine Adenosis: Diagnostic Challenges and Pitfalls.
    Asirvatham JR; Falcone MM; Kleer CG
    Arch Pathol Lab Med; 2016 Oct; 140(10):1045-51. PubMed ID: 27684975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.